Clinical Study on Shiva Guggulu and Baluka Swedana in The Management of Aamvata (Rheumatoid Arthritis) In Children

Introduction: Juvenile Rheumatoid Arthritis is an autoimmune, non-infective and inflammatory joint disease of children. It is most common form of arthritis in children. Rheumatoid arthritis can be co-related with Aamvata, but no clear reference is found about its relation to juvenile age group. There is no clear description of Aamvata in Brihatrayi. Firstly, Aamvata has been described as an independent disease in Madhava Nidaan. It is a disease of Madhyam Rog Marga as it affects Sandhi (joints) and Hridya Marma (heart). Aam and Vata are playing important role in the pathogenesis of this disease. The affliction of Sandhis by Vata dosha in association with Aam reflects the equal role of both dosha and dushya in the causation of the disease. The responsible factor for Objectives: To evaluate the efficacy of Shiva Guggulu and Baluka Swedana in the management of Aamvata. Methods: Thirty subjects diagnosed with Aamvata were selected. The selected children were treated with Shiva Guggulu twice daily for 45 days along with Baluka Swedana once daily with one-week gap in 2 sitting of 7 days. Thus total 3 times (24) Baluka Swedana was advocated to selected patients. Results: Treatment was found to be statistically extremely significant (P<0.0001) with respect to subjective and objective parameters during the course of Shiva Guggulu and Baluka Swedana. Conclusion: It was concluded that the trail drug Shiva Guggulu & Baluka Swedana gave statistically extremely significant effect in the subjective & objective parameter of Aamvata. No any adverse effects were observed during study.